Avenue Therapeutics Ownership | Who Owns Avenue Therapeutics?


OverviewForecastFinancialsChart

Avenue Therapeutics Ownership Summary


Avenue Therapeutics is owned by 1.12% institutional investors, and 98.88% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.47% of its assets in Avenue Therapeutics shares.

ATXI Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAvenue Therapeutics1.12%-98.88%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20231-25,000-37.49%134.79%1---
Mar 31, 20231-39,992-1-1---
Jun 30, 20221614.29%673,937-35.25%312.46%6-25.00%7133.33%
Mar 31, 202214-6.67%1,040,903-55.93%42.44%814.29%3-40.00%
Dec 31, 202115-16.67%2,361,894116.90%1433.26%7-22.22%5-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Extended Market Index6.72K0.47%-2.83K
Fidelity Series Total Market Index1.58K0.11%1.50K
Vanguard Institutional Extnd Mkt Idx Tr618.000.04%-
Spartan Extended Market Index Pool E38.000.00%38.00
NT Ext Equity Mkt Idx Fd - NL7.000.00%-
Northern Trust Extended Eq Market Idx6.000.00%-
NT Ext Equity Mkt Idx Fd - L6.000.00%-
NT Ext Equity Mkt Idx Fd - DC - NL - T26.000.00%-
State St US Extended Mkt Indx NL Cl C3.000.00%-
SSgA U.S. Extended Market Index Class I193.000.00%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 02, 2024Herskowitz Neil-Sell$46.00
Nov 05, 2024KRANZLER JAY D-Sell$136.64
Sep 30, 2024KRANZLER JAY D-Buy$1.24K
Sep 27, 2024KRANZLER JAY D-Buy$7.20
Dec 11, 2023Davidow Robert L-Sell$17.92K

Insider Transactions Trends


DateBuySell
2024 Q4-2
2024 Q32-
2024 Q2--
2024 Q1--
2023 Q4-6

ATXI Ownership FAQ


Who Owns Avenue Therapeutics?

Avenue Therapeutics shareholders are primarily institutional investors at 1.12%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Avenue Therapeutics's industry, Biotech Stocks , is 47.04%, which Avenue Therapeutics falls below.

Does Blackrock own Avenue Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Avenue Therapeutics.

Who is the top mutual fund holder of Avenue Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Avenue Therapeutics shares, with 0.47% of its total shares outstanding invested in 6.72K Avenue Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools